July 11th 2025, 3:00pm
The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic castration-resistant prostate cancer.
July 11th 2025, 1:00pm
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
July 10th 2025, 9:00pm
I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.
July 10th 2025, 8:00pm
Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone living with metastatic disease.
July 10th 2025, 7:05pm
Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural causes than from their cancer.
July 10th 2025, 5:00pm
After nearly 11 years of living with Hodgkin lymphoma, my sister Kathleen passed away peacefully at 39, leaving me to navigate the sorrow of losing her.
July 10th 2025, 4:03pm
Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic castration-sensitive prostate cancer.
July 10th 2025, 3:00pm
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy.
July 10th 2025, 1:00pm
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia.
July 9th 2025, 9:00pm
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients
Expert Explains Need for Better Outcomes in Resectable Lung Cancer